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Abstract 
Background. Hyperglycemia was reported to harm liver and induce metabolic inbalance.  The 
tree bark of Cinnamomum burmannii (C. burmanii) was potential as anti-hiperglycemic agent. 
The bark was rich with secondary metabolites that may lead to possess other advantages for 
diabetes.  
Objectives. To study the effect of aqueos extract of C.burmannii (AEC) on liver and metabolic 
condition by measuring necrotic hepatocytes, serum urea and uric acid levels in alloxan-
induced diabetic rats (AIDRs). 
Methods. Three groups of fasted rats (free allowed to water) were intraperitoneally injected 
with 150 mg/Kg BW in 1 ml normal saline 6 hours prior to intraperitoneal injection of 2 ml  
10% glucose  to induce  AIDRs, the animals were allowed to 5% glucose solution for 24 hours 
afterward. The AIDRs were treated with 0.5 ml, 1ml, and 2 ml of AEC respectively for 2 weeks. 
Hematoxyline-Eosine-stained liver slices were observed for necrotic hepatocytes by light 
microscope. Serum urea and uric acid levels were measured by Glutamate dehydrogenase and 
Uricase-PAP methods respectively. Data were analyzed by ANOVA followed by LSD test, p 
values of < 0.05 were considered to be significant. 
Results.  
The given doses of AEC lowered urea and uric acid serum levels of AIDRs (p = 0.000) which 
approximated to the non diabetic rats’s serum levels (p > 0.05). Except the smallest dose, the 
remaining doses of AEC reduced necrotic hepatocytes number in AIDRs  (p = 0.000). 
Conclusion. 
Aqueos extract of C.burmannii protected hepatocytes and corrected serum urea and uric acid 
levels of alloxan-induced diabetic rats. 
  
Keywords: Cinnamomum burmanii; diabetes; necrotic hepatocytes; serum urea: serum uric 
acid. 
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INTRODUCTION 
Diabetes is a disorder characterized 
by chronic hyperglycaemia, and has 
commonly  been subclassified into type 1 
diabetes (T1DM) (with insulin-secreting β 
cells destruction by autoimmune 
mechanism) and type 2 diabetes (T2DM) 
(with insulin resistance and metabolic 
syndrome)1. Hyperglycemia has been 
reported to involve in activation of polyol 
pathway, AGE generation, ROS 
production, and RAGE activation2,3, which 
collectively will lead to diabetic 
complications. ROS production associated 
with hyperglycemia have been shown to 
have significant role in the pathogenesis of  
liver function  impairment and the 
development of NASH4,5. Liver biopsy on 
136 patients at their first diagnoses of 
T2DM showed NASH was found in more 
than 90% of them  and  it was suggested that 
NASH may be  early complication of 
T2DM on liver due to its  pathogenesis 
correlating with insulin resistance.6   
Active constituents of medicinal plants are 
being considered for potent antidiabetic 
effects.7 Such plants contain substantial 
amounts of cardiac glicoside, phenolics, 
alkaloids, steroids, flavonoids, saponins, 
and tannins which are being suggested as 
potent agents against diabetes.8 WHO 
recommended the evaluation of plants 
traditionally used to control diabetes 
because they are effective, non-toxic, with 
less or no side effects, and  promoted  them 
as  candidates for oral therapy.9  
Cinnamomum was reported as a plant with 
many health benefits as it have properties 
such as anti-inflammatory, antimicrobial, 
antioxidant, antitumor, cholesterol-
lowering and also have cardivascular, 
immunomudulatory , insulin mimetic , 
hypoglycemic effects.10 There are 4 main 
species of cinnamomum namely: C. 
zeylanicum, C. cassia, C. burmannii, and C. 
loureirii. The inner bark of the plant contain 
aromatic essential oils with characteristic 
flavor and aroma. The higher the level of 
the oils , the stronger the flavor. 
Cinnamomum is rich in polyphenol which 
are natural antioxidant.11 Some phenolic 
compunds in the essential oil of the four  
cinnamomum species have been mentioned 
above were cinnamaldehyde, coumarine, 
proanthocyanine, catechine, epicatechine, 
procyanidins B1, proanthocyanidins as 
major compounds. Among the four 
cinnamomum species,  C. burmannii (grows 
in Indonesia) contains the highest amount 
of cinnamaldehyde and  has a smoother 
taste with less bite than C. cassia and C. 
loureirii.11  The combination of aqueous 
extract of P. crocatum  (local name, Sirih 
merah) and of C. burmannii was 
traditionally used as functional beverage. A 
such combination was reported to have no 
harmful signs on liver, kidney, and blood of 
rats.12   The suplementation of C. burmannii 
in cacao drink lead to return the antioxidant 
level of the drink.13  Cinnamomum has been 
granted generally recognized as safe 
(GRAS) status as a food additive by the 
U.S. food and drug administration (FDA). 
14 Many previous studies reported the active 
subtances of cinnamomum have anti-
hyperglycemic action by mechanism of 
enhanced insulin secretion, inhibition of 
alanine absorption in the rat intestine 
(alanine plays important role in 
gluconeogenesis), insuline-like activity, 
enhanced insulin secretion, amelioration of 
oxidative stress in the pancreas.15 The 
present study reported other benefit effects 
of C. burmanii inspite of its ability to 
correct blood glucose. This is an initial 
study of aqueous extract of C. burmannii 
(AEC) potency in affecting serum urea and 
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uric acid level, and hepatocytes conditions 
in aloxan induced-diabetic rats (AIDRs). 
  
SUBJECTS AND METHODS 
Plant collection and Extraction 
C.burmannii powder was obtained from 
Materia Medica-Batu, Malang. The powder 
was dried, 10 g of it was mixed  with 100 
ml of water prior to save the solution in 
waterbath at 60°C for 2 hours. The aqueous 
extract was filtered to obtaine filtrat. Finally 
add the filtrat with aquadest until the 
volume up to  1000 ml. The amount of C. 
burmannii powder and extraction technique 
were adopted from Perdana et al, 2017. This 
study applaid 3 kinds of  AEC doses 
namely; 0.5 ml, 1 ml, and 2 ml of which 
must have originated from aqueous extracts 
of 5 mg, 10 mg, and 20 mg of C. burmannii 
powder respectively.  
 
Experimental Animals 
Twenty five of  male Wistar rats breeding 
at Biomedicine Laboratory of Brawijaya 
University. The ages were between 2 and 3 
month, weighing about  200-300 g.  The 
rats were randomly divided into 5 groups 
and housed in environment with a normal 
ambient temperature and humidity. 
Lighting period was 12 h daily. The 
research protocols were approved by 
Animal Ethical Commitee of Brawijaya 
University.  
 
Induction of Experimental Diabetes and  
C. burmannii Administration. 
18 hours-fasted rats (free access to water) 
were intraperitoneally injected with 150 
mg/ Kg BW of aloxan in 1 ml of normal 
saline, 6 hours afterward the rats were 
intraperitoneally injected with 10 % 
glucose solution. Then the rats were free 
allowed to 5 % glucose solution for 24 
hours. The tail blood glucose was detected 
by glucometer in 72 hours later. 
Hyperglycemia was exist when blood 
glucose > 200 mg/dl. 
Three groups of AIDRs begin to recieve 
oral  0.5 ml, 1 ml, 2 ml of AEC respectively 
at day 4 after the intraperitoneally injection 
of 10% glucose solution. They recieve oral 
extracts every day for 14 days. The two 
other groups were healthy rats and AIDRs 
recieving no extract of C. burmannii. All 
groups of rats were sacrificed  18 days after 
alloxan injection. 
 
Blood and Liver Collection  
Rats were anesthesized by ether. 
Intracardiac blood was aspirated and put in 
EDTA containing centrifuge tubes then 
centrifuge at 3000 rpm for 10 minutes. 
Liver was gently cleaned by neutral buffer 
solution. The organs were put in 10% 
formaline for fixation. Blood and liver were 
saved in refrigerator at -4°C. 
 
Measurement of Urea and Uric Acid 
Serum. 
Urea serum: Urea serum was measured 
based on Coupled- enzyme calorimetric 
methods adopted from Sampson  et al, 
1980.16 Briefly, preparing the enzymic 
reagent contains, per liter: Buffer pH 7,8 
120 mmol/Ll, ADP 0.7 mmol/L, urease ≥ 7 
kU/L, glutamate dehydrogenase 0.4 kU/L. 
The substrat reagent contains: 2-
Oxoglutarat 5 mmol/L and  NADH 0.25 
mmol/L. The enzymatic and substrat 
reagents  were stored at − 4°C and 4°C 
respectively for no longer than 15 days. 40 
ml of enzymatic reagent and 10 ml of 
substrate reagent were mixed prior to be 
added into 10 µl serum or plasma then 
mixing the contents by gentle inversion. 
The samples were put in waterbath at 30°C 
for 30 minutes before reading  with 
sphectrophotometer at λ 334 nm (the 
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cuvetes temperature were at 30°C).   
Absorbance reading were also done for 
standarts and blanko solution. The 
absorbance value  was the difference 
absorbance value between sample and 
blanko solution. The values were   
converted into serum urea nitrogen 
concentrations by means of standart 
solution curve.  
Uric acid serum: Uric acid serum was 
measured by Uricase-PAP method. Reagen 
composition: phosphate buffer solution 50 
mmol/L, 4-Aminophenazone (PAP) 0.3 
mmol/L, 3,5-dichloro-2-
Hydroxybenzenesulfonic acid (DCHBS) 4 
mmol/L, Uricase > 200 U/L, and 
peroxidase > 1000 U/L. Briefly; 20 µl of 
serum was mixed with the reagent then was 
incubated at 20-25°C for 10 minutes. 
Absorbance reading was at λ 546 nm. 
Standart of  urea concentration- absorbance 
curve was used to find the urea serum 
concentrations. 
 
Hepatic Tissue Slices Staining and  Necrotic 
Hepatocytes measurement. 
Liver was blocked with paraffin and cut the 
liver paraffine block by rotary microtome to 
obtaine 4 μm thick-slice. The slices were 
stained by Hematoxyline-Eosine. Necrotic 
hepatocytes of  zona 1, 2, and 3 of lobulus were 
detected in 5 difference field of views by 
binocular light microscope (magnificient 
1000X). Necrotic hepatocytes were 
characterized by membrane lysis, protein 
denaturation, eosinophilic cytoplasma, 
homogenous clear, and nuclear changes such 
as; karyolysis, picnosis, and karyorrhexis.   
Data analysis 
Data were statistical analyzed by ANOVA 
and followed by LSD test. Mean 
differences < 0.05 was considered to be 
significant. 
 
RESULTS 
Table 1. Mean±SD of necrotic hepatocytes numbers 
in  zona 1, 2, dan 3 of liver lobulus of healhty rats, 
AIDRs, and AIDRs recieving AEC. 
Groups of 
Rats 
n Mean±SD  of necrotic 
hepatocytes numbers in respect 
with the lobulus zone  
  Zone 1 Zone 2 Zone 3 
Healthy 5 0.520 ± 
0.6419a 
0.720 ± 
0.6723* 
0.440 ± 
0.2608Ø 
AIDRs 5 23.720 ± 
3.5174b 
24.360 ± 
4.3460¶ 
25.360 ± 
9.0768¤ 
AIDRs + 
0.5 ml AEC 
5 21.520 ± 
3.4774b 
22,520 ± 
3.2668¶ 
23.560 ± 
5.9387¤ 
AIDRs + 
1 ml AEC 
5 4.600 ± 
3.3466c 
3.600 ± 
2.2091* 
2.520 ± 
3.4543Ø 
AIDRs + 
2 ml AEC 
5 4.320 ± 
2.3178a 
3.560 ± 
1.8515* 
2.880 ± 
1.9697Ø 
Different notation in every mean values of each zone 
column indicates statistically significant difference 
(p<0.05). AEC, Aqueous extract of C. burmannii; 
AIDRs, Aloxan induced-diabetic rats. 
 
Table 2. Mean±SD of serum level of urea, uric acid, 
and glucose of healthy rats, AIDRs and  AIDRs 
recieving AEC. 
 
Groups  
of Rats 
 
n 
Serum  
urea level 
(mg/dl) 
Serum  
uric acid 
level 
(mg/dl) 
Serum  
Glucose 
level 
(mg/dl) 
Healthy 5 47.420 ±, 
7.9698*±6
98* 
1.540 ± 
0.493* 
114.80 ± 
8.167* 
AIDRs 5 156.680 ± 
19.7003¶ 
2.460 ± 
0.5177¶ 
431.40 ± 
28.211¶ 
AIDRs + 
0.5 ml AEC 
 
5 57. 480 ± 
5.2447* 
1.340 ± 
0.2702* 
467.00 ± 
66.765¶ 
AIDRs + 
1 ml AEC 
 
5 64.640 ± 
18.0166* 
1.380 ± 
0.2490* 
454.00 ± 
62.940¶ 
AIDRs + 
2 ml AEC 
 
5 63.480 ± 
24.2400* 
1.340 ± 
0.2793* 
276.20 ± 
197.994¥ 
*,¶,¥: Different notation presented statistically 
significant difference (p<0.05). 
LSD test between AIDRs recieving AEC is 
unsignificantly different (p>0,05). AEC, Aqueous 
extract of C. burmannii; AIDRs, Aloxan induced 
diabetic rats. 
 
DISCUSSION 
Aqueous extract of C.burmannii reduced 
necrotic hepatocytes and serum glucose 
level of AIDRs.  
The present study showed 
intraperitoneally injection of single dose 
alloxan at 150 mg/ KgBW significanly 
developed hyperglycemia and  necrotic 
hepatocytes (table 1 and 2). A study used 
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intraperitoneal alloxan at dose of 120 
mg/Kg BW to induce diabetes and the 
accompanying liver injury to study the 
effect of ethyl acetate fraction of Sida 
cordata on liver disorder.17 Using alloxan at 
dose 42 mg/Kg BW administered into tail 
vein another research showed that  alloxan-
induced diabetes causes changes in rat 
livers that resemble the patogenesis of 
chronic fatty liver disease in humans.18 Our 
previous study on alloxan (150 mg/Kg BW) 
induced diabetes of rats showed that iNOS 
serum level of AIDRs increased 
(p=0.007).19  Inductive nitric oxide synthase 
(iNOS) catalized the reaction producing 
NO radicals playing a role in many diseases 
(including diabetes mellitus) in which the 
pathogenesis involve oxidative stress.20 
Experimental diabetes induced by 
intraperitoneal single dose of 150 mg/Kg 
BW alloxan were used to study histological 
changes of hepatocytes due to 
hyperglycemia.21,22  As oxidative stress 
plays the crucial role in liver cells injuries 
caused by hyperglycemia, antioxidants are 
understandably considered to be a good 
therapeutic strategy for the treatment of 
liver disorders.5 The present study showed 
oral AEC at dose of 2 ml has the best 
performance in reducing necrotic 
hepatocytes of AIDRs. The 2 ml dose of 
AEC reduced blood glucose but did not 
approximate the glucose level of the 
healthy rats (Table 2). Aqueous extract of 
C. burmannii bark has antioxidant activity 
higher than the ethanolic extract, the 
phytochemical analysis of AEC  indicated 
that polyphenols (including flavonoid and 
tannin) and phenolic volatile oil compounds 
as the major antioxidant.23 
Aqueous extract of C.burmannii lowered 
serum uric acid and urea level. 
Prospective cohort studies provided strong 
evidence that high level of serum uric acid 
is a risk factor  for developing T2DM in 
middle aged and older people. Therefore, 
controlling hyperuricemia might be a future 
strategy for the T2DM prevention.24  
A study of hyperuricemia prevalence of 641 
T2DM patients (34-91 years) in Lagos, 
Nigeria provided it was 25%.25 
Hyperuricemia in T2DM is a risk factor for 
developing of cardiovascular 
complication,26 retinophaty and 
albuminuria,27, peripheral neurophaty.28, 
and nephropathy.29 Our study provided that 
intraperitoneally administration of single 
dose of 150 mg/KgBW alloxan 
significantly increased serum uric acid level 
of rats. The given doses of AEC reduced 
serum uric acid levels significantly 
compared with AIDRs recieving no AEC 
(Table 2). It was strongly supposed that 
high level of uric acid in alloxan- induced 
diabetic rats were caused by renal 
impairment.30 Intraperitoneal 
administration of alloxan at dose 120 mg 
induced  a deposit of eosinophilic materials 
in the intermediate substantial of medulla in 
the kidney of diabetic rats.31 Uric acid is the 
end product of purin (guanosine, inosine, 
and adenosine) metabolism. A series of 
reaction were needed to converts purin into 
xantine. The latter will be oxidized into uric 
acid in a reaction catalized by xanthine 
oxidase (XOD).32 In human, genes and high 
ingestion of purin, fructose, alcohol were 
factors increasing uric acid serum.33,34   We 
did not measure AIDRs body weight, but 
Idakwoji,( 2015) reported that 
intraperitoneal injection of single dose 
alloxan at 150 mg/kgBW lowered   wistar 
rats body weight.35  Respecting with this 
finding, it was stongly proposed that  the 
reduction of the rat’s body weight is 
accompanied with increased 
glycogenolysis, lipolysis, gluconeogenesis 
and these biochemical activities result in 
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loss of body tissue protein and fat.36 A cross 
sectional study in croatians found the 
prevalence of hyperuricemia in adult is 
10,7% and seems to be associated with 
prediabetic condition.37 A Literature study 
reviewed the evidence that hyperuricemia 
may have a key role in the pathogenesis of 
insulin resistance by blocking endothelial 
nitric oxide supply. Thus it was speculated 
that hyperuricemia and insulin resistance 
share bidirectional causal effects.38 The 
final product of protein catabolism  is urea 
will be secreted through kidney.39 Previous 
study reported that urea serum level of 
diabetic patient and alloxan induced-
diabetes rats were increased due to kidney 
impairment.40,41 Our study showed the three 
doses of AEC able to significantly reduced 
serum urea levels in AIDRs, as a note the 
serum urea levels after AEC administration 
were unsignificantly different compared 
with those of healthy rats (Tabel 2).  
 
CONCLUSION 
Aqueous extract of C. burmannii might has 
potency to protect hepatocyte necrosis, 
corrects serum urea and uric acid level in 
alloxan induced-diabetic rats  due to 
diabetes mellitus in which oxidative stress 
may play role in the patogenesis.  
SUGGESTIONS 
We proposed to explore the optimum dose 
of aqueous extract of C. burmannii for 
reducing blood glucose on the Alloxan –
induced diabetic rats. 
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